NO20005570D0 - Cyklopentanondihydropyridinforbindelser anvendbare som kaliumkanalÕpnere - Google Patents
Cyklopentanondihydropyridinforbindelser anvendbare som kaliumkanalÕpnereInfo
- Publication number
- NO20005570D0 NO20005570D0 NO20005570A NO20005570A NO20005570D0 NO 20005570 D0 NO20005570 D0 NO 20005570D0 NO 20005570 A NO20005570 A NO 20005570A NO 20005570 A NO20005570 A NO 20005570A NO 20005570 D0 NO20005570 D0 NO 20005570D0
- Authority
- NO
- Norway
- Prior art keywords
- cyclopentanone
- compounds useful
- potassium channel
- channel openers
- dihydropyridine compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
- C07C45/298—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with manganese derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Gynecology & Obstetrics (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/262,441 US6518279B2 (en) | 1999-03-04 | 1999-03-04 | Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
PCT/US2000/005828 WO2000051986A1 (en) | 1999-03-04 | 2000-03-06 | Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20005570L NO20005570L (no) | 2000-11-03 |
NO20005570D0 true NO20005570D0 (no) | 2000-11-03 |
Family
ID=22997528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20005570A NO20005570D0 (no) | 1999-03-04 | 2000-11-03 | Cyklopentanondihydropyridinforbindelser anvendbare som kaliumkanalÕpnere |
Country Status (20)
Country | Link |
---|---|
US (1) | US6518279B2 (no) |
EP (1) | EP1075466A1 (no) |
JP (1) | JP2003517454A (no) |
KR (1) | KR20010043295A (no) |
CN (1) | CN1318053A (no) |
AR (1) | AR028987A1 (no) |
AU (1) | AU3616800A (no) |
BG (1) | BG104999A (no) |
BR (1) | BR0005189A (no) |
CA (1) | CA2330541A1 (no) |
CO (1) | CO5150208A1 (no) |
HU (1) | HUP0102895A3 (no) |
IL (1) | IL139140A0 (no) |
MX (1) | MXPA00010790A (no) |
NO (1) | NO20005570D0 (no) |
PL (1) | PL343883A1 (no) |
SK (1) | SK18152000A3 (no) |
TR (1) | TR200003202T1 (no) |
WO (1) | WO2000051986A1 (no) |
ZA (1) | ZA200005798B (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6265417B1 (en) | 1997-12-18 | 2001-07-24 | Abbott Laboratories | Potassium channel openers |
US6593335B1 (en) | 1997-12-18 | 2003-07-15 | Abbott Laboratories | Potassium channel openers |
US7074931B2 (en) | 2000-08-02 | 2006-07-11 | Astrazeneca Ab | Process for asymmetric synthesis of substituted 1,4 -dihydropyridines |
US20030045449A1 (en) * | 2001-08-15 | 2003-03-06 | Pfizer, Inc. | Pharmaceutical combinations for the treatment of neurodegenerative diseases |
US20030199578A1 (en) * | 2002-04-19 | 2003-10-23 | Turner Sean C. | Naphthalene amides as potassium channel openers |
US7674793B2 (en) * | 2006-02-10 | 2010-03-09 | Janssen Pharmaceutica Nv | Tricyclic dihydropyrazines as potassium channel openers |
WO2010094405A1 (en) | 2009-02-18 | 2010-08-26 | Bayer Schering Pharma Aktiengesellschaft | Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof |
WO2021253180A1 (en) * | 2020-06-15 | 2021-12-23 | Novartis Ag | Methyl (r) -2- (fluoromethyl) -5-oxo-4-phenyl-4, 5, 6, 7-tetrahydro-1h-cyclopenta [b] pyridine-3-carboxylate and methyl (r) -2- (fluoromethyl) -5-oxo-4-phenyl-1, 4, 5, 7-tetrahydrofuro [3, 4-b] pyridine-3-carboxylate as cav1.2 activators |
US11939316B1 (en) | 2023-11-06 | 2024-03-26 | King Faisal University | 9-(6-flouro-2-hydroxyouinolin-3-yl)-10-(2-hydroxyethyl)-3,6-diphenyl-3,4,6,7,9,10-hexhydroacridine-1,8(2h,5h)-dione as an antimicrobial compound |
US11970478B1 (en) | 2023-11-16 | 2024-04-30 | King Faisal University | 9-(2-hydroxyquinolin-3-yl)-10-(2-hydroxyethyl)-3,3,6,6-tetramethyl-3,4,6,7,9,10-hexahydroacridine1,8(2H,5H)-dione as an antimicrobial compound |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2003148A1 (de) | 1970-01-24 | 1971-07-29 | Bayer Ag | Neue 1,4-Dihydropyridinderivate |
DE3447170A1 (de) | 1984-12-22 | 1986-07-03 | Bayer Ag, 5090 Leverkusen | Mischung unterschiedlicher dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
GB8716971D0 (en) | 1987-07-17 | 1987-08-26 | Pfizer Ltd | Therapeutic agents |
GB8907401D0 (en) | 1989-04-01 | 1989-05-17 | Pfizer Ltd | Therapeutic agents |
CA2080949A1 (en) | 1991-10-21 | 1993-04-22 | Cyrus John Ohnmacht | Therapeutic agents |
GB9220570D0 (en) | 1991-10-21 | 1992-11-11 | Ici Plc | Therapeutic agent |
GB9318935D0 (en) | 1992-10-20 | 1993-10-27 | Zeneca Ltd | Heterocyclic derivatives |
DE4313690A1 (de) | 1993-04-27 | 1994-11-03 | Bayer Ag | Kondensierte Chinolyl-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln |
DE69823227T2 (de) | 1997-12-18 | 2005-03-10 | Abbott Laboratories, Abbott Park | Kaliumkanalöffner |
-
1999
- 1999-03-04 US US09/262,441 patent/US6518279B2/en not_active Expired - Fee Related
-
2000
- 2000-03-01 CO CO00014719A patent/CO5150208A1/es unknown
- 2000-03-02 AR ARP000100931A patent/AR028987A1/es not_active Application Discontinuation
- 2000-03-06 MX MXPA00010790A patent/MXPA00010790A/es unknown
- 2000-03-06 PL PL00343883A patent/PL343883A1/xx not_active Application Discontinuation
- 2000-03-06 AU AU36168/00A patent/AU3616800A/en not_active Abandoned
- 2000-03-06 CA CA002330541A patent/CA2330541A1/en not_active Abandoned
- 2000-03-06 TR TR2000/03202T patent/TR200003202T1/xx unknown
- 2000-03-06 BR BR0005189-6A patent/BR0005189A/pt not_active IP Right Cessation
- 2000-03-06 KR KR1020007012257A patent/KR20010043295A/ko not_active Application Discontinuation
- 2000-03-06 WO PCT/US2000/005828 patent/WO2000051986A1/en not_active Application Discontinuation
- 2000-03-06 IL IL13914000A patent/IL139140A0/xx unknown
- 2000-03-06 HU HU0102895A patent/HUP0102895A3/hu unknown
- 2000-03-06 SK SK1815-2000A patent/SK18152000A3/sk unknown
- 2000-03-06 JP JP2000602213A patent/JP2003517454A/ja not_active Withdrawn
- 2000-03-06 CN CN00800760A patent/CN1318053A/zh active Pending
- 2000-03-06 EP EP00914832A patent/EP1075466A1/en not_active Withdrawn
- 2000-10-18 ZA ZA200005798A patent/ZA200005798B/en unknown
- 2000-11-03 NO NO20005570A patent/NO20005570D0/no not_active Application Discontinuation
- 2000-11-28 BG BG104999A patent/BG104999A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL139140A0 (en) | 2001-11-25 |
JP2003517454A (ja) | 2003-05-27 |
SK18152000A3 (sk) | 2001-06-11 |
MXPA00010790A (es) | 2002-06-04 |
NO20005570L (no) | 2000-11-03 |
TR200003202T1 (tr) | 2001-08-21 |
ZA200005798B (en) | 2002-01-18 |
US6518279B2 (en) | 2003-02-11 |
US20020007065A1 (en) | 2002-01-17 |
CN1318053A (zh) | 2001-10-17 |
PL343883A1 (en) | 2001-09-10 |
EP1075466A1 (en) | 2001-02-14 |
CA2330541A1 (en) | 2000-09-08 |
CO5150208A1 (es) | 2002-04-29 |
KR20010043295A (ko) | 2001-05-25 |
HUP0102895A2 (hu) | 2001-12-28 |
AU3616800A (en) | 2000-09-21 |
BR0005189A (pt) | 2001-01-09 |
AR028987A1 (es) | 2003-06-04 |
HUP0102895A3 (en) | 2002-01-28 |
BG104999A (en) | 2001-10-31 |
WO2000051986A1 (en) | 2000-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1133474T3 (da) | 3-Substituerede 4-arylquinolin-2-onderivater som kaliumkanal-modulatorer | |
NO20003930L (no) | Sammensetninger som inneholder organiske forbindelser | |
NO20033683D0 (no) | 2,4-disubstituerte pyrimidin-5-karboksamidderivater som KCNQ kaliumkanal modulatorer | |
NO20014412D0 (no) | Forbindelser nyttige som anti-inflammatoriske midler | |
DK2253620T3 (da) | Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer | |
GB2390091B (en) | Bisarylamines as potassium channel openers | |
NO20042955L (no) | Substituerte fenylaftalener som estrogene midler | |
DK1451192T3 (da) | Ny krystallinsk forbindelse | |
DK1326858T3 (da) | Piperidinforbindelser som anti-allergiske midler | |
DE50108085D1 (de) | Furchenöffner | |
DK1522539T3 (da) | Krystallinsk komposition indeholdende excitalopram | |
NO20022649L (no) | Heterocykliske dihydropyrimidiner som kaliumkanal inhibitorer | |
AU5557700A (en) | New uses for potassium channel openers | |
AU2003251955A1 (en) | Platinum compound | |
DK1339685T3 (da) | Biphenylcarboxamider, der er egnede som lipidsænkende midler | |
NO20005570L (no) | Cyklopentanondihydropyridinforbindelser anvendbare som kaliumkanalåpnere | |
NO20013860D0 (no) | 16-hydroksyostratriener som selektive ostrogener | |
DE60331767D1 (de) | beta-1,4-MANNOBIOSE ENTHALTENDE ZUSAMMENSETZUNG | |
DK1075471T3 (da) | Idolylderivater som serotonerge midler | |
AU2003205961A1 (en) | Photo-sensitive composition | |
AU2003223899A1 (en) | Seal for spindles | |
AU2003258562A1 (en) | Thermally labile bleaching composition | |
DE50012652D1 (de) | Laufwerkdichtung | |
SI1499590T1 (sl) | Piperidinski derivati kot blokatorji kalijevih kanalov | |
AU2003203035A1 (en) | 1,4-dihydropyridine and pyridine compounds as calcium channel blockers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |